Multiple genes/multiple autoantigens role in Type 1 diabetes

Clinical Reviews in Allergy and Immunology

Volumn 18, Issue 1, 2000, Pages 27-40

  Abiru, Norio ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; HLA ANTIGEN; INSULIN;

ALLELE; AUTOIMMUNITY; CHROMOSOME 6; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; REVIEW; T LYMPHOCYTE;

EID: 0034086498     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1385/CRIAI:18:1:27     Document Type: Review

References (85)

1. 1. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314:1360-1368.
2. 2. Bach J-F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994; 15:516-542.
3. 3. Nepom GT. Immunogenetics and IDDM. Diabetes Rev 1993; 1:93-103.
4. 4. Eisenbarth GS, Ziegler A. Type I Diabetes Mellitus. In: Weintraub BD (ed.) Molecular Endocrinology: Basic Concepts and Clinical Correlations. 1st ed. New York: Raven Press, 1995, pp. 269-282.
5. 5. Bellgrau D, Pugliese A. NOD mouse and BB rat: genetics and immunologic function. In: Eisenbarth GS, Lafferty KJ (eds.) Type I Diabetes: Molecular, Cellular, and Clinical Immunology. 1st ed. New York, New York: Oxford University Press, 1996, pp. 53-75.
6. 6. Redondo MJ, Rewers M, Jackson R, Yu L, Garg S, Pilcher CC, et al. Anti-islet autoimmunity is primarily genetically determined as evidenced by autoantibody expression of monozygotic twins, dizygotic twins and siblings of patients with type I diabetes: a prospective case-control study. BMJ 1999; 318:698-702.
7. 7. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371:130-136.
8. 8. Kawasake E, Noble J, Erlich H, Mulgrew CL, Fain PR, Eisenbarth GS. Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes 1998; 47:1971-1973.
9. 9. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci USA 1988; 85:8111-8115.
10. 10. Todd JA, Bell JI, McDevitt HO. HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329:599-604.
11. 11. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 1990; 322:1836-1841.
12. 12. Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Huffman M, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996; 39:807-812.
13. 13. Fain, P, Eisenbarth, GS. Genetics of type 1 diabetes mellitus. In: Baxter J, Melmed S, New M, Martin L (eds.) Geneticus in Endocrinology. Lippincott-Raven, Philadephia, PA, 1999.
14. 14. Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C, et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type I diabetes. Nat Genet 1997; 15:293-297.
15. 15. Bennett ST, Lucassen AM, Gough SCL, Powell EE, Undlien DE, Pritchard LE, et al. Suspectibility to human type I diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9:284-292.
16. 16. Bennett ST, Wilson AJ, Cucca F, Nerup J, Pociot F, McKinney PA, et al. IDDM2-VNTR-encoded suspectibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J Autoimmun 1996; 9:415-421.
17. 17. Pugliese A, Awdeh ZL, Alper CA, Jackson RA, Eisenbarth GS. The paternally inherited insulin gene B allele (1,428 FokI site) confers protection from insulin-dependent diabetes in families. J Autoimmun 1994; 7:687-694.
18. 18. Lernmark Å, Ott J. Sometimes it's hot, sometimes it's not. Nat Genet 1998; 19:213,214.
19. 19. Concannon P, Gogolin-Ewens KJ, Hinds DA, Wapelhorst B, Morrison VA, Stirling B, et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998; 19:292-296.
20. 20. Mein CA, Esposito L, Dunn MG, Johnson GCL, Timms AE, Goy JV, et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998; 19:297-300.
21. 21. Verge CF, Vardi P, Babu S, Bao F, Erlich HA, Bugawan T, et al. Evidence for oligogenic inheritance of type 1A diabetes in a large Bedouin Arab family. J Clin Invest 1998; 102:1569-1575.
22. 22. Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Zanchetta R, et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 1997; 82:939-942.
23. 23. Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalles CL, et al. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clin Exp Immunol 1997; 107:341-346.
24. 24. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 1996; 81:1871-1876.
25. 25. Yu L, Brewer, KW, Gates S, Wang T, Babu S, Gottlieb PA, et al. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 1999; 84:328-335.
26. 26. Petronzelli F, Multari G, Ferrante P, Bonamico M, Rabuffo G, Campea L, et al. Different dose effect of HLA-DQαβ heterodimers in insulin-dependent diabetes mellitus and celiac disease susceptibility. Hum Immunol 1993; 36:156-162.
27. 27. Carter C, Sheldon W, Walker C. The inheritance of coeliac disease. Ann Hum Genet 1959; 23:266-278.
28. 28. Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, Eisenbarth GS. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease associated to transglutaminase autoantibodies. J Autoimmune 1999; 13:143-148.
29. 29. Yu L, Eisenbarth GS. Immunology of type 1 diabetes and related endocrine disorders. Clin Endocrinol 1998; 257-266.
30. 30. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2:1279-1283.
31. 3H recombinant human ligands. J Immunol Methods 1995; 186:89-99.
32. 32. Kaprio J, Tuomilehto J, Koshenvuo M, Romanov K, Reunanen A, Eriksson J, et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1993; 35:1060-1067.
33. 33. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA. Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992; 41:183-186.
34. 34. Gianani R, Rabin DU, Verge CF, Yu L, Babu S, Pietropaolo M, et al. ICA512 autoantibody radioassay. Diabetes 1995; 44:1340-1344.
35. 35. Lan MS, LU J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994; 13:505-514.
36. 36. Zhang B, Lan MS, Notkins AL. Autoantibodies to IA-2 in IDDM: location of major antigenic determinants. Diabetes 1997; 46:40-43.
37. 37. Christie MR. Islet cell autoantigens in type I diabetes. Eur J Clin Invest 1996; 26:827-838.
38. 38. Pietropaolo M, Hutton JC, Eisenbarth GS. Protein tyrosine phosphatase-like proteins: link with IDDM. Diabetes Care 1996; 20:208-214.
39. 39. Greenbaum CJ, Palmer JP. Humoral immune markers: insulin antibodies. In: Palmer JP (ed.) Prediction, Prevention, and Genetic Counseling in IDDM. Chichester, England: Wiley, 1996, pp. 63-76.
40. 40. Naserke HE, Dozio N, Ziegler A-G, Bonifacio E. Comparison of a novel microassay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 1998; 41:681-683.
41. 41. Aanstoot H-J, Kang S-M, Kim J, Lindsay L, Roll U, Knip M, et al. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type I diabetes. J Clin Invest 1996; 97:2772-2783.
42. 42. Atkinson MA, Maclaren NK. Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest 1993; 92:1608-1616.
43. 43. Gianani R, Eisenbarth GS. Humoral autoimmunity. In: Eisenbarth GS, Lafferty KJ (eds.) Type I Diabetes: Molecular, Cellular, and Clinical Immunology. 1st ed. New York City, New York: Oxford University Press, 1996:209-229.
44. 44. Martin S, Lampasona V, Dosch M, Pietropaolo M. Islet cell autoantigen 69 antibodies in IDDM. Diabetologia 1996; 39:747.
45. 45. Elias D, Cohen IR. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 1995; 44:1132-1138.
46. 46. Mcevoy RC, Thomas NM, Ness J. Humoral immune markers: additional islet cell antigens: important clues to pathogenesis or red herrings? In: Palmer JP (ed.) Prediction, Prevention, and Genetic Counseling in IDDM. Chichester, England: Wiley, 1996:97-108.
47. 47. Buschard K, Josefsen K, Horn T, Fredman P. Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus Lancet 1993; 342:840.
48. 48. Dotta F, Gianani R, Previti M, Lenti L, Dionisi S, D'Erme M, et al. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes 1996; 45:1193-1196.
49. 49. Eisenbarth GS. Combinatorial autoantibody screening for prediction of type I diabetes. Clin Res 1993; 41:154A Abstract.
50. 50. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte M-T, et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43:1304-1310.
51. 51. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45:926-933.
52. 52. Eisenbarth GS, Gianani R, Yu L, Pietropaolo M, Verge CF, Chase HP, et al. Dual parameter model for prediction of type 1 diabetes mellitus. Proc Assoc Am Physicians 1998; 110:126-135.
53. 53. Haskins K, Wegmann D. Diabetogenic T-cell clones. Diabetes 1996; 45:1299-1305.
54. 54. Wegmann DR, Norbury-Glaser M, Daniel D. Insulin-specific T cells are a pre-dominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 1994; 24:1853-1857.
55. 55. Wegmann DR, Gill RG, Norbury-Glaser M, Schloot N, Daniel D. Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun 1994; 7:833-843.
56. 56. Daniel D, Gill RG, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995; 25:1056-1062.
57. 57. Simone E, Daniel D, Schloot N, Gottlieb P, Babu S, Kawasaki E, et al. T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci USA 1997; 94:2518-2521.
58. 58. Daniel D, Wegmann DR. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci U S A 1996; 93:956-960.
59. 59. Zekzer D, Wong FS, Wen L, Altieri M, Gurlo T, von Grafenstein H, et al. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes 1997; 46:1124-1132.
60. 60. Atkinson MA, Bowman MA, Kuo-Jang K, Campbell L, Dush PJ, Shah SC, et al. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 1993; 329:1853-1858.
61. 61. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994; 94:2125-2129.
62. 62. Durinovic-Bello I, Hummel M, Ziegler AG. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996; 45:795-800.
63. 63. Brooks-Worrell BM, Starkebaum GA, Greenbaum C, Palmer JP. Peripheral blood mononuclear cells of insulin-independent diabetic patients respond to multiple islet cell proteins. J Immunol 1996; 157:5668-5674.
64. 64. Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, et al. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles of T lymphocytes of recent onset IDDM patients. J Clin Invest 1997; 99:2405-2415.
65. 65. Schloot NC, Roep BO, Wegmann DR, Yu L, Wang TB, Eisenbarth GS. T cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM patients and control subjects. Diabetologia 1997; 40:332-338.
66. 66. Schloot NC, Roep BO, Wegmann DR, Yu L, Chase P, Wang T, et al. Altered immune response to insulin to newly diagnosed compared to insulin-treated diabetic patients and health control subjects. Diabetologia 1997; 40:564-572.
67. 67. Pugliese A, Bugawan T, Moromisato R, Awdeh ZL, Alper CA, Jackson RA, et al. Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes. J Clin Invest 1994; 2447-2452.
68. 68. Castano L, Ziegler AG, Ziegler R, Shoelson S, Eisenbarth GS. Characterization of insulin autoantibodies in relatives of patients with type 1 diabetes. Diabetes 1993; 42:1202-1209.
69. 69. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 1993; 341:927,928.
70. 70. Eisenbarth GS, Jackson RA, Pugliese A. Insulin autoimmunity: the rate limiting factor in pre-type I diabetes. J Autoimmun 1992; 5 (suppl A):241-246.
71. 71. Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS. Life table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 1989; 38:1320-1325.
72. 72. Vardi P, Ziegler AG, Matthews JH, Dib S, Keller RJ, Ricker AT, et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care 1988; 11:736-739.
73. 73. Petersen JS, Russel S, Marshall MO, Kofod H, Buschard K, Cambon N, et al. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 1993; 42:484-495.
74. 74. Julier C, Hyer RN, Davies J, Merlin F, Soularue P, Briant L, et al. Insulin-IGF2 region on chromosome lip encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 1991; 354:155-159.
75. 75. Lucassen AM, Julier C, Beressi J-P, Boitard C, Froguel P, Lanthrop M, et al. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet 1993; 4:305-310.
76. 76. Owerbach D, Gabbay KH. Localization of a type 1 diabetes susceptibility locus to the variable tandem repeat region flanking the insulin gene. Diabetes 1993; 42:1708-1714.
77. 77. Tompkins SM, Moore JC, Jensen PE. An insulin peptide that binds an alternative site in class II major histocompatibility complex. J Exp Med 1996; 183:857-866.
78. 78. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88:10,252-10,256.
79. 79. Bergerot I, Fabien N, Maguer V, Thivolet C. Oral insulin induces CD4+ regulatory cells that protect NOD mice from adoptive transfer of diabetes. J Immunol 1994; Abstract.
80. 80. Harrison LC, Dempsey-Collier M, Kramer DR, Takahashi K. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp med 1996; 184:2167-2174.
81. 81. Muir A, Peck A, Clare-Salzler M, Song Y-H, Cornelius J, Luchetta R, et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 1995; 95:628-634.
82. 82. Karounos DG, Bryson JS, Colhen DA. Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. J Clin Invest 1997; 100:1344-1348.
83. 83. Hartmann B, Bellmann K, Ghiea I, Kleemann R, Kolb H. Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant. Diabetologia 1997; 40:902-909.
84. 84. Hancock WW, Polansky M, Zhang J, Blogg N, Weiner HL. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am J Pathol 1995; 147:1193-1199.
85. 85. Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliott JF, Leiter EH. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens. Diabetes 1997; 46:1975-1982.